Amgen (AMGN) Announces BLINCYTO Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia

Go back to Amgen (AMGN) Announces BLINCYTO Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia

Amgen (AMGN) Declares $1.76 Quarterly Dividend; 3.1% Yield

March 3, 2021 4:39 PM EST

Amgen (NASDAQ: AMGN) declared a quarterly dividend of $1.76 per share, or $7.04 annualized.

The dividend will be payable on June 8, 2021, to stockholders of record on May 17, 2021, with an ex-dividend date of May 14, 2021.

The annual yield on the dividend is 3.1 percent.

For a... More